Chronic Disease Management Platforms Market Report 2026

Chronic Disease Management Platforms Market Overview

• Chronic Disease Management Platforms market size has reached to $8.33 billion in 2025 • Expected to grow to $16.72 billion in 2030 at a compound annual growth rate (CAGR) of 15% • Growth Driver: Growing Prevalence Of Lifestyle-Related Diseases Driving The Growth Of The Market Due To Increasing Sedentary Behavior • Market Trend: Advancing Personalized Digital Healthcare Through Remote Monitoring Solutions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Chronic Disease Management Platforms Market?

Chronic disease management platforms refer to digital healthcare solutions that support the continuous monitoring, coordination, and management of long-term health conditions such as diabetes, cardiovascular diseases, asthma, and chronic respiratory disorders. These platforms leverage data integration, remote monitoring, analytics, and communication tools to enable proactive care, improve treatment adherence, and support clinical decision-making across care pathways. The main types of chronic disease management platforms include solutions and services. Solutions refer to digital or software-based systems designed to monitor, track, and support long-term disease care and patient engagement. These platforms are categorized by disease type including cardiovascular diseases, diabetes, cancer, respiratory diseases, and other disease types, while the end-user healthcare providers and healthcare payers.

What Is The Chronic Disease Management Platforms Market Growth Forecast?

The chronic disease management platforms market size is expected to see rapid growth in the next few years. It will grow to $16.72 billion in 2030 at a compound annual growth rate (CAGR) of 15.0%. The growth in the forecast period can be attributed to integration of AI in clinical decision support systems, expansion of value based healthcare models, growth in remote patient monitoring programs, increasing interoperability of healthcare data systems, rising adoption of personalized medicine approaches. Major trends in the forecast period include AI powered predictive chronic disease risk analytics platforms, iot enabled remote patient monitoring ecosystems, cloud based interoperable electronic health record integration systems, precision medicine driven personalized chronic care pathways, blockchain enabled secure patient data exchange platforms.

Global Chronic Disease Management Platforms Market Segmentation

1) By Type: Solutions, Services 2) By Disease Type: Cardiovascular Diseases, Diabetes, Cancer, Respiratory Diseases, Other Disease Types 3) By End User: Healthcare Providers, Healthcare Payers Subsegments: 1) By Solutions: Population Health Management Solutions, Care Management Solutions, Patient Engagement Solutions, Telehealth Solutions, Remote Patient Monitoring Solutions, Clinical Decision Support Solutions, Healthcare Analytics Solutions 2) By Services: Consulting Services, Implementation And Integration Services, Training And Education Services, Support And Maintenance Services, Managed Services

What Is The Driver Of The Chronic Disease Management Platforms Market?

The growing prevalence of lifestyle-related diseases is expected to propel the growth of the chronic disease management platforms market going forward. Lifestyle-related diseases refer to illnesses that are primarily caused by unhealthy habits and behaviors such as poor diet, physical inactivity, smoking, and excessive alcohol consumption. The growing prevalence of lifestyle-related diseases is due to increasing sedentary behavior, as more people spend prolonged hours sitting at desks, using digital devices, and engaging in minimal physical activity. Chronic disease management platforms enable continuous monitoring, personalized care, medication tracking, and early risk detection to help manage lifestyle-related disorders such as diabetes, obesity, hypertension, and cardiovascular diseases. For instance, in June 2024, according to the National Health Service, a UK-based government department, in 2023, the NHS identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This represents a significant increase compared to 3,065,825 in 2022, highlighting a rise of nearly 20%. Therefore, the growing prevalence of lifestyle-related diseases is driving the growth of the chronic disease management platforms industry.

Key Players In The Global Chronic Disease Management Platforms Market

Major companies operating in the chronic disease management platforms market are Oracle Corporation, Koninklijke Philips N.V., Baxter International Inc., Epic Systems Corporation, Teladoc Health Inc., athenahealth Inc., Innovaccer Inc., Amwell, CareCloud Inc., Greenway Health LLC, Arcadia Solutions LLC, DarioHealth Corp., Omada Health Inc., TimeDoc Health LLC, ChartSpan Medical Technologies Inc., Vida Health Inc., HealthSnap Inc., Optimize Health Inc., CareHarmony LLC, Murphi AI Inc., Mahalo Health Inc., KangarooHealth Inc.

Global Chronic Disease Management Platforms Market Trends and Insights

Major companies operating in the chronic disease management platforms market are focusing on developing innovative solutions, such as digital therapeutics and remote patient monitoring platforms, to enhance patient engagement, improve medication adherence, and enable real-time chronic disease tracking and personalized care delivery. Digital therapeutics and remote monitoring platforms are technology-driven healthcare solutions that combine connected medical devices, mobile applications, cloud-based analytics, and clinical support tools to monitor and manage chronic conditions remotely, offering a more proactive and data-driven alternative to traditional in-person disease management approaches. For instance, in December 2025, the U.S. Food and Drug Administration (US FDA) launched the Total Product Life Cycle Advisory Program (TAP) Pilot, an initiative designed to accelerate the development and commercialization of innovative medical devices and digital health technologies, including chronic disease management solutions. The program provides early and strategic regulatory guidance, interactive feedback, and collaborative support to medical device developers throughout the product lifecycle. It aims to improve patient access to high-quality digital healthcare technologies by streamlining regulatory pathways and enhancing product safety, effectiveness, and interoperability.

What Are Latest Mergers And Acquisitions In The Chronic Disease Management Platforms Market?

In March 2026, Health Recovery Solutions LLC, a US–based healthcare technology company, acquired Rimidi Inc. for an undisclosed amount. With this acquisition, Health Recovery Solutions aims to strengthen and expand its remote patient monitoring and chronic care management capabilities by integrating Rimidi’s EHR-connected clinical workflows, diabetes management tools, and continuous glucose monitoring (CGM) expertise into its enterprise virtual care platform. Rimidi Inc. is a US–based healthcare technology company that specializes in providing EHR-integrated remote patient monitoring software, chronic disease management solutions, and connected care tools.

Regional Outlook

North America was the largest region in the chronic disease management platforms market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Chronic Disease Management Platforms Market?

The chronic disease management platforms market includes revenues earned by entities by providing services such as software-as-a-service (SaaS) platform subscriptions, remote patient monitoring, care coordination and workflow automation, electronic health record (EHR) integration, predictive analytics and clinical decision support, telehealth and virtual care enablement, patient engagement tools, data analytics and reporting, implementation and system integration, customization of digital care pathways, training and support services, and ongoing maintenance and upgrades. The market value includes the value of related goods and embedded digital tools sold by the service provider or included within the platform offering. Only goods and services traded between entities or provided directly to end users are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Chronic Disease Management Platforms Market Report 2026?

The chronic disease management platforms market research report is one of a series of new reports from The Business Research Company that provides chronic disease management platforms market statistics, including chronic disease management platforms industry global market size, regional shares, competitors with a chronic disease management platforms market share, detailed chronic disease management platforms market segments, market trends and opportunities, and any further data you may need to thrive in the chronic disease management platforms industry. This chronic disease management platforms market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.